Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
E3 ubiquitin-protein ligase TRIM48 is a member of the tripartite motif (TRIM) protein family, characterized by a RING finger, one or two B-box domains, and a coiled-coil region[1][5][8]. TRIM48 functions as an E3 ubiquitin ligase that promotes K48-linked polyubiquitination and subsequent proteasomal degradation of specific substrates, notably protein arginine methyltransferase 1 (PRMT1)[1][3][8][9]. By targeting PRMT1, TRIM48 facilitates activation of apoptosis signal-regulating kinase 1 (ASK1), increasing oxidative stress-induced cell death, and suppresses FOXO1 transcriptional activity by preventing its methylation[3][8]. In the immune system, TRIM48 acts as a negative feedback regulator of RIG-I-mediated signaling, modulating antiviral responses and interferon production[4]. TRIM48 is implicated in cancer, immune modulation, and possibly other diseases, but no drugs are currently known to directly target it.
Targeting TRIM48 would generally modulate protein ubiquitination pathways, influencing degradation of specific targets such as PRMT1 and pathways like ASK1-mediated apoptosis and antiviral signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E3 ubiquitin-protein ligase TRIM48 (TRIM48).